EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effect of prebiotics on gastrointestinal symptoms and quality of life in children with intestinal failure: A pilot study

Rut Anne Thomassen iD, Janne Anita Kvammen, Beint S Bentsen, Marianne Bratlie, Siv Kjølsrud Bøhn, Hanne Farstad, Christian Kahrs, Linh Ngo, Camilla Nybø, Camilla Sæland, Erling Tjora, Rune Rose Tronstad und 3 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.70186 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Rut Anne Thomassen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Gastrointestinal Diseases, Intestinal Failure, Prebiotics, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: South-Eastern Norway Regional Health Authority, Throne Holst Nutrition Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Children with intestinal failure (IF) have a substantial disease burden, with significant gastrointestinal (GI) symptoms, abnormal stool patterns and reduced health‐related quality of life (HRQOL). This study examined the effects of prebiotic supplementation on GI symptoms and HRQOL.

Methods

An open‐label, randomised controlled trial involving two phases. In Phase 1, children aged 1–18 years with IF received supplementation with a blend of prebiotics for 4 weeks. In Phase 2, participants were randomised to either continue supplementation or cease supplementation for 6 months to evaluate long‐term effects. Primary end points included parent‐reported GI symptoms and HRQOL, measured by PedsQL™ scales. Secondary end points were stool consistency and frequency, nutritional support and antibiotic use.

Results

Out of 47 children completing Phase 1, 43 completed Phase 2 (24 in the intervention group, 19 in the control group). After 4 weeks, 60% reported reduced GI symptoms. By the end of Phase 2, the intervention group showed no significant changes in HRQOL score, but significant GI symptom improvements compared to controls (mean paediatric quality of life inventory GI score difference of 6.9, p = 0.01). Stool frequency decreased (median −1.0 vs. 0 stools/day, p = 0.003), and stool consistency normalised more frequently in the intervention group (42% vs. 6%, p = 0.02). No significant changes were noted in nutritional support or antibiotic use.

Conclusion

While HRQOL remained unchanged, short‐ and long‐term prebiotic supplementation significantly improved GI symptoms, stool frequency and stool consistency in children with IF, indicating its potential as a therapeutic option in paediatric IF. Clinical Trial Registration ClinicalTrials.gov ID: NCT04981262 https://clinicaltrials.gov/study/NCT04981262?cond=intestinal%20failure&term=prebiotics&rank=2 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal DiseasesIntestinal FailurePrebioticsQuality of LifeAdolescentChildChild, PreschoolFemaleHumansInfantMalePilot ProjectsTreatment Outcome

Stichwörter der Autor:innen

enteral nutritionhealth‐related quality of lifeparenteral nutrition

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Faculty of Chemistry, Biotechnology and Food Sciences, Norwegian University of Life Sciences, Ås, Norway.
  • Department of Pediatrics, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Department of Pediatrics, Østfold Hospital Trust, Grålum, Norway.
  • Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway.

ORCID-Profile: Rut Anne Thomassen

Förderung

  • South-Eastern Norway Regional Health Authority
  • Throne Holst Nutrition Research Foundation

Zitieren

APA

Thomassen, R. A., Kvammen, J. A., Bentsen, B. S., Bratlie, M., Bøhn, S. K., Farstad, H., Kahrs, C., Ngo, L., Nybø, C., Sæland, C., Tjora, E., Tronstad, R. R., Størdal, K., Brun, A. C., & Henriksen, C. (2025). Effect of prebiotics on gastrointestinal symptoms and quality of life in children with intestinal failure: A pilot study. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70186

Vancouver

Thomassen RA, Kvammen JA, Bentsen BS, Bratlie M, Bøhn SK, Farstad H, et al. Effect of prebiotics on gastrointestinal symptoms and quality of life in children with intestinal failure: A pilot study. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70186

BibTeX
@article{Thomassen2025,
  author = {Thomassen, Rut Anne and Kvammen, Janne Anita and Bentsen, Beint S and Bratlie, Marianne and Bøhn, Siv Kjølsrud and Farstad, Hanne and Kahrs, Christian and Ngo, Linh and Nybø, Camilla and Sæland, Camilla and Tjora, Erling and Tronstad, Rune Rose and Størdal, Ketil and Brun, Anne Charlotte and Henriksen, Christine},
  title = {Effect of prebiotics on gastrointestinal symptoms and quality of life in children with intestinal failure: A pilot study},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.70186}
}
Kostenlos starten →